company

FORSKNINGSFONDET OM NEVROMUSKULÆRE SYKDOMMER

1394 NESBRU

Return on Equity
16,79 %
Current Ratio
468,22
Debt-to-Equity Ratio
0,01
Key figures (NOK)2022
Revenue1 858 000
Net Income1 793 000
Total Assets10 769 000
Total Equity10 676 000
Income (NOK)2022
Revenue1 858 000
Expenditure136 000
Operating Profit1 722 000
Financial Income71 000
Financial Costs0
Financial Balance71 000
Earnings Before Tax1 793 000
Tax0
Net Income1 793 000
Balance (NOK)2022
Total Fixed Assets0
Total Current Assets10 769 000
Total Assets10 769 000
Total Retained Equity8 676 000
Total Equity10 676 000
Total Long-Term Debt69 000
Total Current Debt23 000
Total Equity and Debt10 769 000
Cash flow (NOK)2022
Sales Income0
Other Income1 858 000
Revenue1 858 000
Cost of Goods Sold0
Salary Costs0
Depreciation0
Impairment0
Expenditure136 000
Operating Profit1 722 000
Financial Income71 000
Financial Costs0
Financial Balance71 000
Dividends0
Net Income1 793 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets0
Real Eastate0
Machinery and Plant Facilities0
Fixtures0
Total Tangible Assets0
Total Fiancial Fixed Assets0
Total Fixed Assets0
Stock0
Total Investments8 924 000
Cash, Bank1 844 000
Total Current Assets10 769 000
Total Assets10 769 000
Total Equity10 676 000
Short-Term Group Debt0
Total Long-Term Debt69 000
Creditors5 000
Unpaid Taxes18 000
Dividends0
Other Current Debt0
Total Current Debt23 000
Total Equity and Debt10 769 000
Financial indicators2022
Return on Equity16,79 %
Debt-to-Equity Ratio0,01
Operating Profit Margin92,68 %
Current Ratio468,22
Quick Ratio468,22
Equity Ratio0,99
Gross Profit Margin100 %
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English